Document Detail


Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids.
MedLine Citation:
PMID:  16919516     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Omega-3 fatty acids from both marine and plant sources have been shown to reduce the risk of coronary artery disease death. Although their beneficial cardiovascular effects are thought to be due to their antiarrhythmic properties, omega-3 fatty acids also have been shown to have a wide range of antiatherosclerotic and antithrombotic effects in animal and human studies. Review of the findings of randomized, controlled trials published through August 2005 shows that omega-3 fatty acids of marine origin consistently lower elevated plasma triglyceride levels in a dose-dependent fashion, with greater efficacy at higher triglyceride levels. Smaller effects on lowering blood pressure, improving endothelial function, and increasing plasma levels of high-density lipoprotein cholesterol were also found. No consistent effects on other lipid, hemostatic, inflammatory, glucose tolerance, or plaque stabilization parameters were found. Epidemiologic studies show more consistent reductions in the incidence of nonfatal myocardial infarction and ischemic stroke than do the clinical trials of increased omega-3 fatty acid intake, which suggests important confounding factors in observational studies. Ongoing clinical trials may clarify the non-antiarrhythmic benefits of omega-3 fatty acid supplementation.
Authors:
Jennifer G Robinson; Neil J Stone
Related Documents :
12559986 - Docosahexaenoic acid-containing phosphatidylethanolamine in the external layer of lipos...
2997846 - Proinflammatory properties of unsaturated fatty acids and their monohydroxy metabolites.
1971706 - In vitro study of docosahexaenoic acid incorporation into phosphatidylcholine by enzyme...
2712316 - Liquid chromatographic and fluorescent derivative aerobic degradation studies of dehydr...
12559986 - Docosahexaenoic acid-containing phosphatidylethanolamine in the external layer of lipos...
2313206 - Regulation of bile acid synthesis. iv. interrelationship between cholesterol and bile a...
Publication Detail:
Type:  Journal Article; Review     Date:  2006-05-30
Journal Detail:
Title:  The American journal of cardiology     Volume:  98     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2006 Aug 
Date Detail:
Created Date:  2006-08-21     Completed Date:  2006-09-28     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  39i-49i     Citation Subset:  AIM; IM    
Affiliation:
Department of Epidemiology, University of Iowa, Iowa City, Iowa 52242, USA. jennifer-g-robinson@uiowa.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Anti-Inflammatory Agents / therapeutic use
Apolipoproteins / drug effects,  metabolism
Blood Pressure / drug effects
Coronary Artery Disease / epidemiology,  physiopathology,  prevention & control*
Dose-Response Relationship, Drug
Endothelium, Vascular / drug effects,  metabolism,  physiopathology
Exercise Tolerance / drug effects
Fatty Acids, Omega-3 / administration & dosage,  therapeutic use*
Fatty Acids, Omega-6 / therapeutic use
Fibrinolytic Agents / administration & dosage,  therapeutic use*
Humans
Lipid Peroxidation / drug effects
Lipoproteins / drug effects,  metabolism
Randomized Controlled Trials as Topic
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents; 0/Apolipoproteins; 0/Fatty Acids, Omega-3; 0/Fatty Acids, Omega-6; 0/Fibrinolytic Agents; 0/Lipoproteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Combination therapy with statins and omega-3 fatty acids.
Next Document:  Antiarrhythmic effects of omega-3 fatty acids.